2021 International Congress on Myeloproliferative Neoplasms

 

2021 International Congress on Myeloproliferative Neoplasms
S

Update on the Clinical Status of Commonly Used Drugs in Primary MF

By 2021 International Congress on Myeloproliferative Neoplasms FEATURING Srdan Verstovsek
By 2021 International Congress on Myeloproliferative Neoplasms FEATURING Srdan Verstovsek
0 views
December 14, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
Videos
22:32
2021 International Congress on Myeloproliferative Neoplasms

Hereditary Erythrocytosis

Feat. M. McMullin
21:43
2021 International Congress on Myeloproliferative Neoplasms

Clonal and Nonclonal Thrombocytosis

Feat. J. Spivak
21:07
2021 International Congress on Myeloproliferative Neoplasms

Persistent Leukocytosis and PV Progression: Prognostic and Therapeut…

Feat. J. Mascarenhas
22:50
2021 International Congress on Myeloproliferative Neoplasms

JAK2V617F and Clonal Hematopoiesis

Feat. A. Moliterno
21:36
2021 International Congress on Myeloproliferative Neoplasms

MPN Stem Cell Fitness and the Link to Clinical Outcomes

Feat. J. Scandura
23:26
2021 International Congress on Myeloproliferative Neoplasms

Candidate Drugs for Preventing MPN Progression

Feat. R. Hoffman
19:42
2021 International Congress on Myeloproliferative Neoplasms

Hot Topics in Hypereosinophilic Syndrome

Feat. A. Klion
17:39
2021 International Congress on Myeloproliferative Neoplasms

Novel Agents of Potential Value in the MPN

Feat. N. Pemmaraju
15:12
2021 International Congress on Myeloproliferative Neoplasms

A Novel Machine Learning-Derived Dynamic Scoring System Predicts Ris…

Feat. G. Abu-Zeinah
17:41
2021 International Congress on Myeloproliferative Neoplasms

Exploiting Iron Metabolism to Treat Polycythemia Vera

Feat. Y. Ginzburg
24:03
2021 International Congress on Myeloproliferative Neoplasms

Inflammation in MPNs: Clinical and Therapeutic Aspects

Feat. H. Hasselbalch
20:56
2021 International Congress on Myeloproliferative Neoplasms

Treatment Approaches for Early MF

Feat. R. Mesa
32:24
2021 International Congress on Myeloproliferative Neoplasms

New ELN Recommendations for CML

Feat. R. Hehlmann
17:46
2021 International Congress on Myeloproliferative Neoplasms

Which Published Schemas Are Helpful in MPN Transplant Decisions?

Feat. S. Giralt
22:47
2021 International Congress on Myeloproliferative Neoplasms

Anticoagulant Management in the MPNs

Feat. C. Kessler
20:00
2021 International Congress on Myeloproliferative Neoplasms

Are Hematologists Rational?

Feat. R. Gale
12:42
2021 International Congress on Myeloproliferative Neoplasms

Pediatric MPNs: An Unfamiliar Topic

Feat. N. Kucine
20:20
2021 International Congress on Myeloproliferative Neoplasms

Role of NGS in the Diagnosis and Prognosis of MPNs

Feat. A. Vannucchi
21:09
2021 International Congress on Myeloproliferative Neoplasms

Update on the Clinical Status of Commonly Used Drugs in Primary MF

Feat. S. Verstovsek